Clinical Trials Browser

Recruiting × Radiation Dose Hypofractionation × Head & Neck × Clear all

NCT07447570 2026-03-03

Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06796270 2025-01-28

Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

Phase NA Recruiting

Nasopharyngeal Carcinoma